SAGENT PHARMACEUTICALS Trademark

Trademark Overview


On Friday, April 21, 2006, a trademark application was filed for SAGENT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SAGENT PHARMACEUTICALS trademark a serial number of 78867342. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, April 30, 2011. This trademark is owned by New Hisun Inc. The SAGENT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, diuretics, hormones, diluents, electrolytes, vitamins, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, and sensitizing agents for chemotherapy-resistant tumors; Pre-filled syringes sold filled with alkalizing agents; pre-filled syringes sold filled with analgesics; pre-filled syringes sold filled with anesthetics; pre-filled syringes sold filled with antacids; pre-filled syringes sold filled with anticholinergics; pre-filled syringes sold filled with antihistamines; pre-filled syringes sold filled with anti-infectives; pre-filled syringes sold filled with anti-inflammatory agents; pre-filled syringes sold filled with anticonvulsants; pre-filled syringes sold filled with antidotes; pre-filled syringes sold filled w...
sagent pharmaceuticals

General Information


Serial Number78867342
Word MarkSAGENT PHARMACEUTICALS
Filing DateFriday, April 21, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, April 30, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2008

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, diuretics, hormones, diluents, electrolytes, vitamins, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, and sensitizing agents for chemotherapy-resistant tumors; Pre-filled syringes sold filled with alkalizing agents; pre-filled syringes sold filled with analgesics; pre-filled syringes sold filled with anesthetics; pre-filled syringes sold filled with antacids; pre-filled syringes sold filled with anticholinergics; pre-filled syringes sold filled with antihistamines; pre-filled syringes sold filled with anti-infectives; pre-filled syringes sold filled with anti-inflammatory agents; pre-filled syringes sold filled with anticonvulsants; pre-filled syringes sold filled with antidotes; pre-filled syringes sold filled with antiemetics; pre-filled syringes sold filled with antipsychotics; pre-filled syringes sold filled with anxiolytics; pre-filled syringes sold filled with blood modifiers; pre-filled syringes sold filled with bronchodialators; pre-filled syringes sold filled with cardiovasculars; pre-filled syringes sold filled with diuretics; pre-filled syringes sold filled with hormones; pre-filled syringes sold filled with diluents; pre-filled syringes sold filled with electrolytes; pre-filled syringes sold filled with vitamins; pre-filled syringes sold filled with oncolytics; pre-filled syringes sold filled with immunosuppressive agents; pre-filled syringes sold filled with transplantation agents; pre-filled syringes sold filled with imaging agents; pre-filled syringes sold filled with vascular targeting agents; pre-filled syringes sold filled with sensitizing agents for chemotherapy-resistant tumors; Safety syringe devices sold filled with alkalizing agents; safety syringe devices sold filled with analgesics; safety syringe devices sold filled with anesthetics; safety syringe devices sold filled with antacids; safety syringe devices sold filled with anticholinergics; safety syringe devices sold filled with antihistamines; safety syringe devices sold filled with anti-infectives; safety syringe devices sold filled with anti-inflammatory agents; safety syringe devices sold filled with anticonvulsants; safety syringe devices sold filled with antidotes; safety syringe devices sold filled with antiemetics; safety syringe devices sold filled with antipsychotics; safety syringe devices sold filled with anxiolytics; safety syringe devices sold filled with blood modifiers; safety syringe devices sold filled with bronchodialators; safety syringe devices sold filled with cardiovasculars; safety syringe devices sold filled with diuretics; safety syringe devices sold filled with hormones; safety syringe devices sold filled with diluents; safety syringe devices sold filled with electrolytes; safety syringe devices sold filled with vitamins; safety syringe devices sold filled with oncolytics; safety syringe devices sold filled with immunosuppressive agents; safety syringe devices sold filled with transplantation agents; safety syringe devices sold filled with imaging agents; safety syringe devices sold filled with vascular targeting agents; safety syringe devices sold filled with sensitizing agents for chemotherapy-resistant tumors; Pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; Drug delivery systems sold as an integral component of drugs, namely, intradermal injection system for injection of anesthetics; Injectable drugs and therapeutic solutions for the treatment of cancer injectable drugs and therapeutic solutions for the treatment of psychotic disorders; injectable drugs and therapeutic solutions for the treatment of pain; injectable drugs and therapeutic solutions for the treatment of kidney disease; injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; injectable drugs and therapeutic solutions for the treatment of vitamin deficiencies; injectable drugs and therapeutic solutions for the treatment of electrolyte deficiencies; injectable drugs and therapeutic solutions for the treatment of heartburn; injectable drugs and therapeutic solutions for the treatment of anxiety; injectable drugs and therapeutic solutions for immunosuppression; injectable drugs and therapeutic solutions for imaging; injectable drugs and therapeutic solutions for the treatment of seizures; Injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of psychotic disorders sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of allergies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of kidney disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of vitamin deficiencies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of electrolyte deficiencies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of anxiety sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for immunosuppression sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of seizures sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 27, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAGENT HOLDING CO.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressGEORGETOWN
KY

Party NameNew Hisun Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman
KY

Party NameNew Hisun Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman
KY

Trademark Events


Event DateEvent Description
Tuesday, October 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, October 9, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, October 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 21, 2010EXTENSION 5 GRANTED
Thursday, October 14, 2010EXTENSION 5 FILED
Thursday, October 14, 2010TEAS EXTENSION RECEIVED
Tuesday, April 27, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 26, 2010EXTENSION 4 GRANTED
Thursday, April 15, 2010EXTENSION 4 FILED
Thursday, April 15, 2010TEAS EXTENSION RECEIVED
Monday, November 2, 2009EXTENSION 3 GRANTED
Thursday, October 29, 2009EXTENSION 3 FILED
Thursday, October 29, 2009TEAS EXTENSION RECEIVED
Friday, March 27, 2009DIVISIONAL PROCESSING COMPLETE
Friday, March 6, 2009DIVISIONAL REQUEST RECEIVED
Friday, March 27, 2009EXTENSION 2 GRANTED
Friday, March 6, 2009EXTENSION 2 FILED
Friday, March 27, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 6, 2009TEAS REQUEST TO DIVIDE RECEIVED
Friday, March 6, 2009TEAS EXTENSION RECEIVED
Friday, March 6, 2009TEAS STATEMENT OF USE RECEIVED
Wednesday, March 4, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 29, 2008EXTENSION 1 GRANTED
Wednesday, October 29, 2008EXTENSION 1 FILED
Wednesday, October 29, 2008TEAS EXTENSION RECEIVED
Tuesday, April 29, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 5, 2008PUBLISHED FOR OPPOSITION
Wednesday, January 16, 2008NOTICE OF PUBLICATION
Friday, December 14, 2007WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, December 1, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, December 1, 2007ASSIGNED TO LIE
Friday, October 26, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 26, 2007EXAMINER'S AMENDMENT ENTERED
Friday, October 26, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 26, 2007EXAMINERS AMENDMENT E-MAILED
Friday, October 26, 2007EXAMINERS AMENDMENT -WRITTEN
Saturday, September 29, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 28, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 28, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 14, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 14, 2007NON-FINAL ACTION E-MAILED
Tuesday, August 14, 2007NON-FINAL ACTION WRITTEN
Tuesday, July 24, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 24, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 24, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 12, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 12, 2007NON-FINAL ACTION E-MAILED
Tuesday, June 12, 2007NON-FINAL ACTION WRITTEN
Monday, June 11, 2007PETITION GRANTED - REMAIL OFFICE ACTION
Thursday, June 7, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 7, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 7, 2007PETITION TO REVIVE-RECEIVED
Monday, May 7, 2007PAPER RECEIVED
Wednesday, April 25, 2007ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, April 25, 2007ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 27, 2006NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2006NON-FINAL ACTION WRITTEN
Monday, September 25, 2006ASSIGNED TO EXAMINER
Thursday, April 27, 2006NEW APPLICATION ENTERED IN TRAM